tiprankstipranks
Trending News
More News >
Humacyte (HUMA)
:HUMA
US Market

Humacyte (HUMA) Income Statement

Compare
1,278 Followers

Humacyte Income Statement

Last quarter (Q4 2024), Humacyte's total revenue was $7.23M, a decrease of -33.01% from the same quarter last year. In Q4, Humacyte's net income was $-20.94M. See Humacyte’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 1.56M$ 1.26M$ 1.49M
Gross Profit
$ 0.00$ -76.55M$ -6.69M$ 1.21M$ -6.94M
Operating Expenses
$ 114.40M$ 23.50M$ 84.58M$ 81.21M$ 64.60M
Depreciation and Amortization
$ 0.00$ 7.72M$ 8.26M$ 8.28M$ 8.43M
EBITDA
$ -114.40M$ -96.46M$ 2.49M$ -72.97M$ -56.25M
Operating Income
$ -114.40M$ -100.05M$ -84.58M$ -81.21M$ -64.60M
Other Income/Expenses
$ 0.00$ -10.73M$ 72.61M$ 54.73M$ -1.92M
Pretax Income
$ 0.00$ -110.78M$ -11.96M$ -26.48M$ -66.52M
Net Income
$ 0.00$ -110.78M$ 64.22M$ 37.54M$ -68.73M
Per Share Metrics
Basic EPS
$ -1.26$ -1.07$ 0.62$ 0.94$ -5.52
Diluted EPS
$ -1.26$ -1.07$ 0.62$ 0.94$ -5.52
Weighted Average Shares Outstanding
118.48M 103.42M 103.05M 39.97M 12.45M
Weighted Average Shares Outstanding (Diluted)
118.48M 103.42M 103.05M 39.97M 12.45M
Currency in USD

Humacyte Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis